Filed: 2/14/2023ACC: 0001420506-23-000635
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 90 equity positions with a total reported market value of $349.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
90
Positions
$349.55M
Total AUM (reported)
27.44M
Total Shares
Allocation by class
EQUITIES$290.45M83.1%
LONG OPTION PUTS$46.15M13.2%
LONG OPTION CALLS$12.95M3.7%
WARRANTS$4.5K0.0%
Portfolio Concentration
Top 3$47.48M13.6%
4–10$69.60M19.9%
11–25$105.29M30.1%
Rest$127.17M36.4%
Top 3 weight
13.6%
Top 10 weight
33.5%
Voting Authority Distribution
Total shares with voting rights: 27.44M
Sole
Full voting authority
27.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole90
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings90
Rows:
Prometheus Bioscience, Inc.
SOLEShares172.40K
TypeSH
Market value$18.96M
5.43%
Sole
172.40K
Shared
0.00
None
0.00
Madrigal Pharmaceuticals Inc
SOLEShares49.90K
TypeSH
Market value$14.48M
4.14%
Sole
49.90K
Shared
0.00
None
0.00
Bellus Health Inc
SOLEShares1.71M
TypeSH
Market value$14.03M
4.02%
Sole
1.71M
Shared
0.00
None
0.00
Poseida Therapeutics Inc
SOLEShares2.23M
TypeSH
Market value$11.82M
3.38%
Sole
2.23M
Shared
0.00
None
0.00
Viewray Inc
SOLEShares2.41M
TypeSH
Market value$10.78M
3.08%
Sole
2.41M
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares253.66K
TypeSH
Market value$10.00M
2.86%
Sole
253.66K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares172.10K
TypeSH
Market value$9.43M
2.70%
Sole
172.10K
Shared
0.00
None
0.00
Anavex Life Science Corp
SOLEShares1.01M
TypeSH
Market value$9.33M
2.67%
Sole
1.01M
Shared
0.00
None
0.00
Immunovant Inc
SOLEShares519.61K
TypeSH
Market value$9.22M
2.64%
Sole
519.61K
Shared
0.00
None
0.00
Nuvalent Inc
SOLEShares302.96K
TypeSH
Market value$9.02M
2.58%
Sole
302.96K
Shared
0.00
None
0.00
Morphic Holding Inc
SOLEShares334.54K
TypeSH
Market value$8.95M
2.56%
Sole
334.54K
Shared
0.00
None
0.00
Alnylam Pharmaceuticals Inc
SOLEShares37.65K
TypeSH
Market value$8.95M
2.56%
Sole
37.65K
Shared
0.00
None
0.00
Madrigal Parmaceuticals, Inc.
SOLEShares30K
TypeSH
Market value$8.71M
2.49%
Sole
30K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares150K
TypeSH
Market value$8.22M
2.35%
Sole
150K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares150K
TypeSH
Market value$8.22M
2.35%
Sole
150K
Shared
0.00
None
0.00
Intra-Cellular Therapies Inc
SOLEShares140.37K
TypeSH
Market value$7.43M
2.13%
Sole
140.37K
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.24M
TypeSH
Market value$7.28M
2.08%
Sole
1.24M
Shared
0.00
None
0.00
Terns Pharmaceuticals Inc
SOLEShares700K
TypeSH
Market value$7.13M
2.04%
Sole
700K
Shared
0.00
None
0.00
Mersana Therapeutics Inc
SOLEShares1.14M
TypeSH
Market value$6.68M
1.91%
Sole
1.14M
Shared
0.00
None
0.00
Biogen Idec Inc
SOLEShares21.98K
TypeSH
Market value$6.09M
1.74%
Sole
21.98K
Shared
0.00
None
0.00
Cerus Corp
SOLEShares1.63M
TypeSH
Market value$5.96M
1.71%
Sole
1.63M
Shared
0.00
None
0.00
Cvrx Inc
SOLEShares314.58K
TypeSH
Market value$5.77M
1.65%
Sole
314.58K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc
SOLEShares352.19K
TypeSH
Market value$5.55M
1.59%
Sole
352.19K
Shared
0.00
None
0.00
Prometheus Biosciences Inc
SOLEShares50K
TypeSH
Market value$5.50M
1.57%
Sole
50K
Shared
0.00
None
0.00
Cincor Pharma Inc
SOLEShares395.38K
TypeSH
Market value$4.86M
1.39%
Sole
395.38K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Prometheus Bioscience, Inc.SOLE | LONG OPTION PUTS | 172.40K | SH | $18.96M 5.43% | 172.40K | 0.00 | 0.00 |
Madrigal Pharmaceuticals IncSOLE | EQUITIES | 49.90K | SH | $14.48M 4.14% | 49.90K | 0.00 | 0.00 |
Bellus Health IncSOLE | EQUITIES | 1.71M | SH | $14.03M 4.02% | 1.71M | 0.00 | 0.00 |
Poseida Therapeutics IncSOLE | EQUITIES | 2.23M | SH | $11.82M 3.38% | 2.23M | 0.00 | 0.00 |
Viewray IncSOLE | EQUITIES | 2.41M | SH | $10.78M 3.08% | 2.41M | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | EQUITIES | 253.66K | SH | $10.00M 2.86% | 253.66K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | EQUITIES | 172.10K | SH | $9.43M 2.70% | 172.10K | 0.00 | 0.00 |
Anavex Life Science CorpSOLE | LONG OPTION PUTS | 1.01M | SH | $9.33M 2.67% | 1.01M | 0.00 | 0.00 |
Immunovant IncSOLE | EQUITIES | 519.61K | SH | $9.22M 2.64% | 519.61K | 0.00 | 0.00 |
Nuvalent IncSOLE | EQUITIES | 302.96K | SH | $9.02M 2.58% | 302.96K | 0.00 | 0.00 |
Morphic Holding IncSOLE | EQUITIES | 334.54K | SH | $8.95M 2.56% | 334.54K | 0.00 | 0.00 |
Alnylam Pharmaceuticals IncSOLE | EQUITIES | 37.65K | SH | $8.95M 2.56% | 37.65K | 0.00 | 0.00 |
Madrigal Parmaceuticals, Inc.SOLE | LONG OPTION PUTS | 30K | SH | $8.71M 2.49% | 30K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | LONG OPTION PUTS | 150K | SH | $8.22M 2.35% | 150K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | LONG OPTION CALLS | 150K | SH | $8.22M 2.35% | 150K | 0.00 | 0.00 |
Intra-Cellular Therapies IncSOLE | EQUITIES | 140.37K | SH | $7.43M 2.13% | 140.37K | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | EQUITIES | 1.24M | SH | $7.28M 2.08% | 1.24M | 0.00 | 0.00 |
Terns Pharmaceuticals IncSOLE | EQUITIES | 700K | SH | $7.13M 2.04% | 700K | 0.00 | 0.00 |
Mersana Therapeutics IncSOLE | EQUITIES | 1.14M | SH | $6.68M 1.91% | 1.14M | 0.00 | 0.00 |
Biogen Idec IncSOLE | EQUITIES | 21.98K | SH | $6.09M 1.74% | 21.98K | 0.00 | 0.00 |
Cerus CorpSOLE | EQUITIES | 1.63M | SH | $5.96M 1.71% | 1.63M | 0.00 | 0.00 |
Cvrx IncSOLE | EQUITIES | 314.58K | SH | $5.77M 1.65% | 314.58K | 0.00 | 0.00 |
Aclaris Therapeutics IncSOLE | EQUITIES | 352.19K | SH | $5.55M 1.59% | 352.19K | 0.00 | 0.00 |
Prometheus Biosciences IncSOLE | EQUITIES | 50K | SH | $5.50M 1.57% | 50K | 0.00 | 0.00 |
Cincor Pharma IncSOLE | EQUITIES | 395.38K | SH | $4.86M 1.39% | 395.38K | 0.00 | 0.00 |
Page 1 of 4